Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

Author(s): Sundström P, Nyström M, Ruuth K, Lundgren E

Abstract

Epitope reactivity of multiple sclerosis (MS) plasma antibodies against the Epstein-Barr virus protein EBNA-1 and its association with HLA DRB1*1501 status was investigated in a case-referent study. Based on EBNA-1 fragment reactivity and the effect of peptide blocking, four 29-36 amino acid long EBNA-1 fragments were selected for detailed studies. MS cases had increased antibody reactivity against several EBNA-1 domains, of which antibodies against EBNA-1 (amino acid 385-420) in HLA DRB1*1501 positive individuals were associated with a 24-fold risk increase for MS. The data need confirmation in a larger sample but suggest a role for this epitope in the autoimmune pathogenesis of MS.

Similar Articles

Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis

Author(s): Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L

Epstein-Barr virus in pediatric multiple sclerosis

Author(s): Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B

Vitamin D and latitude as environmental factors in multiple sclerosis

Author(s): Niino M, Miyazaki Y, Fukazawa T, Kikuchi S

Differential twin concordance for multiple sclerosis by latitude of birthplace

Author(s): Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, et al.

The genetics of multiple sclerosis: An up-to-date review

Author(s): Gourraud PA, Harbo HF, Hauser SL, Baranzini SE

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

Author(s): Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A

Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis

Author(s): Dwyer T, van der Mei I, Ponsonby AL, Taylor BV, Stankovich J, et al.

Prevalence of multiple sclerosis in Isfahan, Iran

Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F

Incidence and prevalence of multiple sclerosis in southeastern Iran

Author(s): Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S

Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time

Author(s): Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, et al.

Prevalence of multiple sclerosis in Isfahan, Iran

Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Author(s): Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al.

Estimation of the dietary requirement for vitamin D in healthy adults

Author(s): Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM, et al.

Nutritional status and anthropometric measurements of patients with multiple sclerosis

Author(s): Saka M, Saka M, Koseler E, Metin S, Bilen S, et al.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis

Author(s): Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, et al.

Dietary intake of vitamin D during adolescence and risk of multiple sclerosis

Author(s): Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, et al.

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study

Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, et al.